T regulatory cells and TGF-β1: Predictors of the host response in mesh complications.
T regulatory cells and TGF-β1: Predictors of the host response in mesh complications.
复制标题
T调节细胞和TGF-β1:网格并发症中宿主反应的预测指标。
DOI:
10.1016/j.actbio.2020.07.051
复制
发表时间:
2020-10-01
影响因子:
9.7
通讯作者:
Moalli PA
中科院分区:
文献类型:
--
作者:
Artsen AM;Liang R;Meyn L;Rytel M;Palcsey S;Abramowitch SD;Moalli PA
Polypropylene mesh is frequently used in urogynecology procedures; however, pain and mesh exposure into the vagina occur in ~10% of cases. Mesh-induced pain, which occurs with or without exposure, persists after removal in 50% of cases. Chronic pain history predicts poor response to mesh removal but only a fraction have this diagnosis. We hypothesize that mesh induced pain is correlated with fibrosis and failure to improve with a heightened inflammatory and fibrotic host response. Women undergoing mesh removal were offered participation in a mesh biorepository. Standardized questionnaires including visual analog scale (VAS) pelvic pain scores were completed at enrollment and 6 months after removal. Responders were considered those with ≥13 mm VAS improvement. 30 mesh-tissue explants were randomly selected for analysis. Samples were labeled for CD8, CD4 (Th) and FoxP3 (Tregs). Peri-fiber collagen deposition (fibrosis) was measured using a customized semi-quantitative assay. Concentrations of TGF-b1, bFGF, MCP-1, PDGF-BB, and IGFBP-1 in tissue were determined by immunoassay and compared to vaginal control biopsies with pathway analysis. VAS pain scores were correlated with degree of histologic fibrosis. Responders had more Tregs (7.8 vs 0.3 per mm2, p = 0.036) and patients were 1.6 times as likely to be a responder for every additional Treg/mm2 (p = 0.05). Pro-fibrotic TGF-β1 was doubled in nonresponders (p = 0.032). On pathway analysis, decreased bFGF and increased PDGF-BB provide a possible mechanism for upregulation of TGF-β1. In conclusion, fibrosis is a plausible mechanism of pain complications and the adaptive immune response likely contributes to mitigation/prevention of complications and recovery in affected patients.
登录
查看更多内容
影响因子:
4.8
作者:
LYSIAK, JJ;HUSSAINI, IM;GONIAS, SL
通讯作者:
GONIAS, SL
影响因子:
2.2
作者:
Klinge, U;Klosterhalfen, B;Schumpelick, V
通讯作者:
Schumpelick, V
影响因子:
3.6
作者:
Adams, WP;Haydon, AS;Brown, SA
通讯作者:
Brown, SA
DOI:
10.1097/spv.0000000000000419
发表时间:
2017-11-01
影响因子:
1.6
作者:
Cardenas-Trowers, Olivia O.;Malekzadeh, Pouran;Hatch, Kenneth D.
通讯作者:
Hatch, Kenneth D.
DOI:
10.1016/j.bbrc.2007.06.121
发表时间:
2007-09-07
影响因子:
3.1
作者:
Meckmongkol, Teerin T.;Harmon, Robert;Van De Water, Livingston
通讯作者:
Van De Water, Livingston